Diamyd Medical AB (publ) (DMYD-B) - Cash Flow Conversion Efficiency

Latest as of February 2026: -0.233x

Based on the latest financial reports, Diamyd Medical AB (publ) (DMYD-B) has a cash flow conversion efficiency ratio of -0.233x as of February 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-39.51 Million ≈ $-4.25 Million USD) by net assets (Skr169.79 Million ≈ $18.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Diamyd Medical AB (publ) defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Diamyd Medical AB (publ) - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Diamyd Medical AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Diamyd Medical AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Diamyd Medical AB (publ) ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Hindprakash Industries Limited NSE:HPIL	0.004x
Theta Edge Bhd KLSE:9075	-0.100x
Dadi Early-Childhood Education Group Ltd TWO:8437	-0.001x
Lottery.com Inc. NASDAQ:SEGG	-0.095x
Observe Medical Asa OL:OBSRV	-0.829x
Immo Mcc NV BR:MCC	N/A
Barnwell Industries Inc NYSE MKT:BRN	-0.216x
Georgia Capital PLC LSE:CGEO	-0.001x

Annual Cash Flow Conversion Efficiency for Diamyd Medical AB (publ) (2010–2025)

The table below shows the annual cash flow conversion efficiency of Diamyd Medical AB (publ) from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see DMYD-B company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-08-31	Skr280.00 Million ≈ $30.13 Million	Skr-169.68 Million ≈ $-18.26 Million	-0.606x	+31.55%
2024-08-31	Skr145.92 Million ≈ $15.70 Million	Skr-129.18 Million ≈ $-13.90 Million	-0.885x	-35.15%
2023-08-31	Skr169.40 Million ≈ $18.23 Million	Skr-110.96 Million ≈ $-11.94 Million	-0.655x	-50.64%
2022-08-31	Skr214.38 Million ≈ $23.07 Million	Skr-93.22 Million ≈ $-10.03 Million	-0.435x	+24.82%
2021-08-31	Skr189.26 Million ≈ $20.37 Million	Skr-109.47 Million ≈ $-11.78 Million	-0.578x	-348.38%
2020-08-31	Skr72.49 Million ≈ $7.80 Million	Skr16.88 Million ≈ $1.82 Million	0.233x	+137.31%
2019-08-31	Skr62.78 Million ≈ $6.76 Million	Skr-39.19 Million ≈ $-4.22 Million	-0.624x	+35.41%
2018-08-31	Skr43.01 Million ≈ $4.63 Million	Skr-41.56 Million ≈ $-4.47 Million	-0.966x	-224.51%
2017-08-31	Skr86.67 Million ≈ $9.33 Million	Skr-25.81 Million ≈ $-2.78 Million	-0.298x	+50.91%
2016-08-31	Skr29.26 Million ≈ $3.15 Million	Skr-17.75 Million ≈ $-1.91 Million	-0.607x	-30.94%
2015-08-31	Skr39.52 Million ≈ $4.25 Million	Skr-18.31 Million ≈ $-1.97 Million	-0.463x	-22.60%
2014-08-31	Skr44.16 Million ≈ $4.75 Million	Skr-16.69 Million ≈ $-1.80 Million	-0.378x	-66.13%
2013-08-31	Skr60.29 Million ≈ $6.49 Million	Skr-13.71 Million ≈ $-1.48 Million	-0.227x	-66.41%
2012-08-31	Skr409.58 Million ≈ $44.08 Million	Skr-55.99 Million ≈ $-6.03 Million	-0.137x	+32.98%
2011-08-31	Skr460.97 Million ≈ $49.61 Million	Skr-94.03 Million ≈ $-10.12 Million	-0.204x	-128.44%
2010-08-31	Skr314.78 Million ≈ $33.88 Million	Skr225.77 Million ≈ $24.30 Million	0.717x	--

About Diamyd Medical AB (publ)

ST:DMYD-B Sweden Biotechnology

Market Cap

$15.69 Million

Skr145.79 Million SEK

Market Cap Rank

#25877 Global

#535 in Sweden

Share Price

Skr1.09

Change (1 day)

-1.81%

52-Week Range

Skr1.02 - Skr17.62

All Time High

Skr71.00